CTR2 Antibody

What is CTR2 and why is it important in cellular copper homeostasis?

CTR2 (also known as SLC31A2, COPT2, or hCTR2) is a membrane protein belonging to the SLC31A transporter family with a canonical amino acid length of 143 residues and a protein mass of 15.7 kilodaltons. It functions primarily in low-affinity copper uptake and is localized in cytoplasmic vesicles, lysosomes, and cellular membranes . CTR2 is widely expressed across many tissue types and plays a critical role in copper transport mechanisms.

Research has revealed that CTR2 interacts with CTR1 (another copper transporter) in vivo and regulates the generation or stability of a truncated form of CTR1 lacking the metal-binding ectodomain . This relationship is significant as knockout studies show that mice lacking CTR2 accumulate higher copper levels in several tissues, with the copper becoming sequestered in endosomal compartments . These findings position CTR2 as a key regulator of both cellular copper uptake and intracellular copper mobilization.

What are the key considerations when selecting a CTR2 antibody for research applications?

When selecting a CTR2 antibody, researchers should consider:

• Target specificity: Ensure the antibody is validated specifically for CTR2/SLC31A2 recognition with minimal cross-reactivity to related proteins like CTR1.

• Species reactivity: Commercial CTR2 antibodies vary in species specificity - available options include those reactive with human, mouse, bacterial, or yeast (Saccharomyces) variants . Confirm compatibility with your experimental model.

• Application compatibility: Different experimental methods require antibodies validated for specific applications. CTR2 antibodies are available for various techniques including Western blot, ELISA, immunohistochemistry (IHC), immunocytochemistry (ICC), and immunofluorescence (IF) .

• Recognition domain: Consider whether the antibody recognizes N-terminal, C-terminal, or internal epitopes, as this affects detection of potential truncated or modified forms of CTR2.

• Validation data: Review scientific literature and manufacturer data showing the antibody's performance, particularly noting observed molecular weights (~15 kDa theoretical, but ~71 kDa observed in some Western blots due to potential multimeric forms) .

How can CTR2 antibodies be optimized for Western blot detection given the discrepancy between theoretical and observed molecular weights?

The optimization strategy should account for the significant discrepancy between CTR2's theoretical molecular weight (15 kDa) and its observed size in Western blots (~71 kDa) . This difference is attributed to CTR2 forming multimeric structures. To optimize Western blot detection:

• Sample preparation: Use gentle lysis buffers (e.g., RIPA with protease inhibitors) to preserve protein complexes if studying multimeric forms. Alternatively, use more stringent conditions with reducing agents if targeting monomeric CTR2.

• Gel selection: Use gradient gels (4-20%) to effectively separate proteins across a wide molecular weight range.

• Transfer conditions: Optimize transfer time and voltage based on protein size. For the larger 71 kDa form, longer transfer times or semi-dry transfer systems may improve results.

• Blocking optimization: Test both BSA and milk-based blocking solutions, as membrane proteins can sometimes show better results with BSA.

• Positive controls: Include MEF whole cell lysate as a suggested positive control sample .

• Antibody dilution optimization: Perform titration experiments to determine optimal primary antibody concentration, typically starting with manufacturer recommendations.

• Validation approach: Consider using CTR2 knockout/knockdown samples as negative controls to confirm specificity of the detected bands.

What are effective protocols for studying CTR2 localization in cellular compartments?

CTR2 is reported to localize in cytoplasmic vesicles, lysosomes, and cellular membranes . To effectively study its subcellular distribution:

• Immunofluorescence approach:

  • Fix cells with 4% paraformaldehyde (10 minutes) followed by permeabilization with 0.1% Triton X-100

  • Use antibodies validated for ICC/IF applications

  • Co-stain with established markers: LAMP1/2 for lysosomes, EEA1 for early endosomes

  • Utilize super-resolution microscopy techniques for detailed colocalization analysis

• Subcellular fractionation:

  • Perform differential centrifugation to isolate membrane, lysosomal, and cytoplasmic fractions

  • Analyze fractions by Western blot using CTR2 antibodies alongside compartment-specific markers

  • Assess enrichment patterns relative to organelle markers

• Epitope accessibility studies:

  • Compare detection with N-terminal versus C-terminal tagged CTR2 constructs

  • Analyze in permeabilized versus non-permeabilized conditions to determine membrane topology

  • This approach has revealed that CTR2 has a similar membrane topology to CTR1, with a cytoplasmic C-terminus

• Live-cell imaging:

  • Generate fluorescently-tagged CTR2 constructs to monitor trafficking dynamics

  • Validate that tagging doesn't alter localization by comparing to antibody-based detection in fixed cells

How can researchers effectively investigate the interaction between CTR2 and CTR1 in copper transport regulation?

The functional relationship between CTR2 and CTR1 represents a sophisticated regulatory mechanism in copper homeostasis, with CTR2 influencing the generation or stability of a truncated form of CTR1 . To investigate this interaction:

• Co-immunoprecipitation strategy:

  • Use CTR2 antibodies to pull down protein complexes from tissue or cell lysates

  • Probe for CTR1 in immunoprecipitates using specific CTR1 antibodies

  • Include appropriate controls (IgG, lysate input)

  • Consider crosslinking approaches for transient interactions

• Genetic manipulation approach:

  • Implement RNAi knockdown of CTR2 and analyze effects on different forms of CTR1

  • Overexpress CTR2 cDNA and measure changes in truncated CTR1 levels

  • Combine with functional assays measuring copper transport

  • Consider CRISPR/Cas9 genome editing for stable knockout models

• Copper level measurement techniques:

  • Inductively coupled plasma mass spectrometry (ICP-MS) for precise tissue copper quantification

  • Correlate changes in CTR2 expression with copper accumulation patterns

  • Analyze both total and subcellular copper distribution

• Truncated CTR1 analysis:

  • Develop antibodies specifically recognizing the truncated form of CTR1

  • Investigate cellular conditions that influence truncation rates

  • Examine kinetics of truncation following copper exposure or CTR2 expression modulation

What analytical approaches can resolve contradictory findings about CTR2 function in different experimental systems?

Current literature suggests multiple potential functions for CTR2: low-affinity copper importer, lysosomal copper exporter, or regulator of cellular macropinocytosis . To reconcile these seemingly contradictory roles:

• Systematic cross-model validation:

  • Compare CTR2 function across multiple cell types and species

  • Standardize experimental conditions for meaningful comparisons

  • Document cell-type specific expression patterns of interacting partners

• Structure-function analysis:

  • Generate domain-specific mutations in CTR2 to determine regions responsible for different functions

  • Assess copper transport capabilities of mutant variants

  • Analyze effects on CTR1 processing with each mutation

• Temporal dynamics assessment:

  • Investigate CTR2 function under varying copper availability conditions

  • Examine acute versus chronic responses to copper stress

  • Monitor real-time trafficking between cellular compartments

• Comprehensive interactome mapping:

  • Perform proteomic analysis of CTR2-associated proteins in different cellular compartments

  • Identify condition-specific protein interactions

  • Validate key interactions through orthogonal methods

How should researchers interpret unexpected molecular weight bands when using CTR2 antibodies in Western blot?

The significant discrepancy between CTR2's theoretical molecular weight (15 kDa) and observed Western blot bands (~71 kDa) presents interpretation challenges . To address this:

• Multimeric form analysis:

  • Vary sample preparation conditions (different detergents, reducing agents)

  • Compare boiled versus non-boiled samples to assess heat-stable complexes

  • Use chemical crosslinkers to stabilize potential protein-protein interactions

  • Compare patterns across different tissue/cell types

• Post-translational modification assessment:

  • Treat samples with glycosidases to identify potential glycosylation

  • Use phosphatase treatment to detect phosphorylation

  • Perform mass spectrometry to identify specific modifications

• Antibody validation approach:

  • Employ CTR2 knockdown/knockout samples as controls

  • Test multiple CTR2 antibodies targeting different epitopes

  • Perform peptide competition assays to confirm specificity

• Comparative migration analysis:

  • Include recombinant CTR2 protein as reference

  • Analyze migration patterns across different gel systems

  • Document tissue-specific variations in observed molecular weights

What strategies can address inconsistent CTR2 antibody staining patterns in immunohistochemistry applications?

Immunohistochemical detection of CTR2 can be challenging due to its membrane protein nature and variable expression levels. To optimize results:

• Antigen retrieval optimization:

  • Compare heat-induced (citrate, EDTA, Tris buffers at varying pH) versus enzymatic retrieval methods

  • Optimize retrieval duration and temperature

  • Test pressure cooker versus microwave heating methods

• Fixation protocol refinement:

  • Compare fresh-frozen versus formalin-fixed paraffin-embedded samples

  • Evaluate fixation duration effects on epitope accessibility

  • Consider dual fixation protocols for membrane proteins

• Signal amplification techniques:

  • Implement tyramide signal amplification for low-abundance detection

  • Use polymer-based detection systems for improved sensitivity

  • Consider proximity ligation assays for protein interaction studies

• Specificity controls:

  • Include tissue from CTR2 knockout models

  • Perform absorption controls with immunizing peptide

  • Compare staining patterns across antibodies targeting different CTR2 epitopes

  • Validate IHC findings with complementary techniques (Western blot, RNA analysis)

How might CTR2 antibodies contribute to understanding copper transport in disease states and therapeutic development?

CTR2's role in copper homeostasis positions it as a potentially important factor in various disease mechanisms:

• Cancer research applications:

  • Investigate CTR2's role in cisplatin resistance, as CTR1 (regulated by CTR2) affects cisplatin uptake

  • Analyze CTR2 expression patterns across cancer types and correlation with treatment response

  • Explore CTR2 inhibition as a strategy to enhance platinum-based chemotherapy effectiveness

• Neurodegenerative disease research:

  • Examine CTR2 expression and localization in models of copper-associated neurodegenerative disorders

  • Investigate age-related changes in CTR2 levels and correlation with copper dysregulation

  • Study potential interactions between CTR2 and disease-associated proteins

• Therapeutic antibody development:

  • Explore function-modulating antibodies targeting CTR2 for disorders of copper metabolism

  • Draw lessons from first-in-class therapeutic antibodies that target related transport systems

  • Assess the potential of CTR2-targeting approaches for restoration of copper homeostasis

• Biomarker applications:

  • Evaluate CTR2 expression patterns as potential diagnostic or prognostic indicators

  • Develop standardized immunohistochemical protocols for clinical assessment

  • Correlate CTR2 levels with disease progression or treatment response

What emerging technologies could enhance CTR2 antibody-based research in the coming years?

The future of CTR2 research will likely benefit from several technological advancements:

• Single-cell analysis techniques:

  • Apply single-cell proteomics to examine cell-to-cell variability in CTR2 expression

  • Utilize imaging mass cytometry for spatial context of CTR2 expression in tissues

  • Develop multiplexed approaches to simultaneously detect CTR2 with interacting partners

• Advanced imaging methodologies:

  • Implement expansion microscopy for nanoscale resolution of CTR2 localization

  • Utilize correlative light and electron microscopy to connect functional data with ultrastructural context

  • Apply live super-resolution microscopy to track CTR2 trafficking in real-time

• CRISPR-based functional genomics:

  • Develop domain-specific CTR2 modifications to dissect function

  • Create conditional knockout systems for temporal control of CTR2 expression

  • Engineer reporter systems for monitoring CTR2 activity in living systems

• Structural biology approaches:

  • Generate structure-specific antibodies based on solved CTR2 protein structure

  • Develop conformation-sensitive antibodies to detect structural changes upon copper binding

  • Create antibodies selective for CTR2 in different oligomeric states